Canada became the first country in the world that has authorized the use of a plant-based COVID-19 vaccine. The two-dose vaccine of Medicago Inc. (a biopharma company owned by Mitsubishi Chemical and Philip Morris), can be given to adults who are aged between 18 to 64, but little data is available on the shots received by people aged 65 and above.
Buy Prime Test Series for all Banking, SSC, Insurance & other exams
The decision to authorize the vaccine was based on a study conducted on 24,000 adults that showed the efficacy rate of the vaccine is 71% at preventing COVID-19 – although the tests were conducted before the omicron variant emerged. Covifenz is the name given to this vaccine. Canada agreed to buy 20 million doses of this plant-based vaccine, with an option to purchase 56 million additional doses.
Important takeaways for all competitive exams:
In 2025, some cities around the world have become home to the highest number of…
India is a country where many different types of fruits are grown because of its…
In a significant development amidst ongoing legal scrutiny, BlackRock, the world’s largest asset manager, has…
Union Minister of Health and Family Welfare, J.P. Nadda, recently launched the Inter-AIIMS Referral Portal…
India and Russia have agreed on six new strategic projects to bolster bilateral investment ties,…
The 9th edition of the Global Technology Summit (GTS), a flagship event co-hosted by the…